Clinical Trials Directory

Trials / Completed

CompletedNCT02739399

Effects of Phenylephrine on Cardiac Preload

The Dynamic Effects of Phenylephrine on Preload and Cardiac Output in Patients Under General Anaesthesia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Algemeen Ziekenhuis Maria Middelares · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

In patients under general anesthesia, episodes of hypotension are often treated with phenylephrine. The effect of phenylephrine is conventionally attributed to afterload increase. The aim of the study is to describe the time course of the effects of phenylephrine on the cardiac preload and cardiac output, and to evaluate whether phenylephrine, as an exclusive alpha-mimetic, could be beneficial for preload optimisation.

Detailed description

In consecutive patients scheduled for laparoscopic sigmoidectomy, all hemodynamic and respiratory variables are recorded electronically for subsequent offline analysis. All patients are ventilated in volume control mode with a tidal volume of 8 ml/kg ideal body weight. During steady-state Target Controlled Infusion (TCI) propofol/remifentanil anesthesia, when the Mean Arterial Blood Pressure (MAP) dropped below 80% of the awake state for at least 5 minutes, a phenylephrine bolus of 2 μg/kg is administered. If necessary this is repeated, or a continuous administration of phenylephrine is started at a rate of 10-30 μg/kg/u. All patient manipulations during the procedure are electronically recorded and time stamped for subsequent off-line data analysis. The first episode in each patient where phenylephrine is administered and in a period of at least 10 minutes when minimal or absent patient manipulation occurred, the hemodynamic variables are analysed to describe the effects of phenylephrine administration on the dynamic preload parameters and macro-hemodynamics.

Conditions

Interventions

TypeNameDescription
DRUGPhenylephrineIntravenous administration

Timeline

Start date
2016-02-01
Primary completion
2016-07-01
Completion
2016-09-01
First posted
2016-04-15
Last updated
2016-12-09

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT02739399. Inclusion in this directory is not an endorsement.